Vol. 3, Issue 8, Part L (2017)

Background and Objectives: The goal of this research was to examine the incidence of psoriatic fatty liver disease in the south Indian population. Research into the incidence of metabolic syndrome in people with psoriasis in south India. Determine if there is a relationship between psoriasis severity and the incidence of NAFLD. The goal of this study is to determine whether or not age, severity, and type of psoriasis are associated with non-alcoholic fatty liver disease and metabolic syndrome.

Methods: Our study, which included 180 people with psoriasis, is a cross-sectional analysis of the condition conducted between January 2016 to December 2016, researchers at Madha Medical College and Research Institute, Chennai, Tamil Nadu, India analyzed data from the hospital's departments of general medicine. Patients with psoriasis who are using hepatotoxic medicines or who are heavy drinkers will not be included in the trial. All patients undergo a battery of diagnostics, including ultrasonography, after a thorough clinical history and physical examination.

Results: In our study, 52.3% of participants with psoriasis also had NAFLD, and 18.5% of participants also had metabolic syndrome. Our results also show an increase in the other features of metabolic syndrome. Psoriasis severity is unrelated to non-alcoholic fatty liver disease. Significant dyslipidemia was seen in psoriasis patients with metabolic syndrome.

Conclusion: There is a strong correlation between psoriasis, metabolic syndrome, and non-alcoholic fatty liver disease (NAFLD). Psoriasis has been shown to have an independent association with NAFLD.